Autopsy report · NCT03948529

RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

“inclusions difficulties.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 4 years before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University Hospital, Lille

Sponsor type

University, hospital or other

Conditions

Leukemia; Graft Failure

Interventions

eltrombopag

Participants

9

Sites

1

Countries

France

Trials that died the same way

• Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
  “inclusion difficulties” (95% match in meaning)
• Comparative Clinical Study Between Virtual Reality Hypnosis and Nitrous Oxide Inhalation for Dental Anxie
  “inclusion challenges” (87% match in meaning)
• Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery
  “lack of inclusions” (82% match in meaning)
• Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
  “lack of inclusion” (79% match in meaning)
• Pronostic Value of Endothelial Dysfunction in Heart Failure
  “Not enough inclusions” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.